US72352L1061 - Common Stock
In the closing of the recent trading day, Pinterest (PINS) stood at $29.49, denoting a -0.41% change from the preceding trading day.
The average brokerage recommendation (ABR) for Pinterest (PINS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
This combination of growth and value stocks has the potential to outperform the broader market in 2025 (and beyond).
Although the stock market had an incredible 2024, not all stocks have been winners.
Morgan Stanley said Pinterest must sustain revenue growth in the mid-to-high teens or achieve acceleration to over 20% if it has to consistently outperform.
I've been actively taking advantage of some recent drops in my favorite stocks.
Advanced Micro Devices and Pinterest turned up in the firm's list of names that offer growth at a reasonable price.
PINS appears to be treading in the middle of the road and investors could be better off if they trade with caution.
Morgan Stanley analysts following Meta stock and Google said the two companies stand as clear beneficiaries if TikTok is banned next month.
Pinterest (PINS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
PINTEREST INC- CLASS A (NYSE:PINS) is not too expensive for the growth it is showing.
When a stock breaks out above the 50-Day simple moving average, good things could be on the horizon. How should investors react?
Meta stock briefly hit all-time highs Wednesday. Analysts say digital ad business is a "natural beneficiary" of strong Cyber Monday spending.
Portfolio moves don't take a holiday off in the world of the widely followed growth investor.
Zacks.com users have recently been watching Pinterest (PINS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Vikram Bhaskaran was leading creator partnerships at Pinterest when his father started showing early symptoms of ALS, a rare, terminal neurodegenerative